Colgate-Palmolive (CL) Beats Expectations as Analysts Raise Price Targets

Colgate-Palmolive Company (NYSE:CL) is included among the 11 Best Rising Dividend Stocks to Buy Right Now.

Colgate-Palmolive (CL) Beats Expectations as Analysts Raise Price Targets

On May 5, Barclays raised its price recommendation on Colgate-Palmolive Company (NYSE:CL) to $80 from $79. It reiterated an Equal Weight rating on the shares. The firm said it believes the company is focusing on achieving a better balance between pricing and volume growth in 2026.

A few days earlier, on May 2, Goldman Sachs raised its price goal on Colgate-Palmolive to $100 from $98. It maintained a Buy rating on the stock. The firm pointed to the company’s stronger-than-expected Q1 results, with both revenue and earnings coming in ahead of expectations. According to the analyst, organic sales growth was higher than anticipated, while broad-based strength across the business also supported slightly better-than-expected gross margins. Goldman Sachs added that EBIT margins remained in line with expectations even as advertising spending increased 10% during the quarter.

Colgate-Palmolive Company (NYSE:CL) focuses on oral care, personal care, home care, and pet nutrition products.

READ NEXT: 12 Best Micro-Cap Dividend Stocks To Buy Now and 10 Best Stocks to Buy Now for a $1 Million Portfolio

Disclosure: None. Follow Insider Monkey on Google News.